Sensei Biotherapeutics, Inc.

NasdaqGM:SNSE Stock Report

Market Cap: US$11.4m

Sensei Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SNSE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders528,8092.1%
Institutions2,223,6388.84%
Private Companies3,648,65414.5%
VC/PE Firms4,426,00017.6%
General Public14,324,27857%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 42.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.6%
Heidrick & Struggles Ventures
4,426,000US$2.0m0%0.03%
14.5%
Cambrian BioPharma, Inc.
3,648,654US$1.7m0%no data
2.58%
Ikarian Capital, LLC
650,000US$295.2k0%0.09%
2.46%
The Vanguard Group, Inc.
618,757US$281.0k0%no data
1.35%
Thomas Ricks
339,397US$154.1k0%no data
0.86%
Renaissance Technologies LLC
215,572US$97.9k-3.67%no data
0.69%
Boothbay Fund Management, LLC
172,835US$78.5k0%no data
0.65%
Geode Capital Management, LLC
163,139US$74.1k0%no data
0.36%
Susquehanna International Group, LLP, Asset Management Arm
90,428US$41.1k0%no data
0.26%
Citadel Advisors LLC
66,044US$30.0k330%no data
0.25%
John Celebi
62,495US$28.4k0%no data
0.19%
Bridgeway Capital Management, LLC
47,900US$21.8k-38.5%no data
0.18%
National Bank Investments Inc.
45,575US$20.7k356%no data
0.16%
Erin Colgan
40,987US$18.6k0%no data
0.14%
Edward Van der Horst
35,445US$16.1k0%no data
0.1%
Northern Trust Global Investments
25,983US$11.8k0%no data
0.1%
State Street Global Advisors, Inc.
25,774US$11.7k0%no data
0.084%
Robert Holmen
21,132US$9.6k0%no data
0.08%
Raymond James Financial Inc., Asset Management Arm
20,000US$9.1k42.9%no data
0.078%
Cresset Asset Management, LLC
19,671US$8.9k0%no data
0.063%
William Ringo
15,955US$7.2k0%no data
0.055%
XTX Holdings Limited, Asset Management Arm
13,926US$6.3k-0.86%no data
0.048%
Morgan Stanley, Investment Banking and Brokerage Investments
12,006US$5.5k0%no data
0.044%
Deuterium Capital Management, LLC
11,000US$5.0k0%0.01%
0.04%
Quint: Essence Capital SA
10,000US$4.5k0%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 06:14
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sensei Biotherapeutics, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhiqiang ShuBerenberg
Samantha Lynn SemenkowCitigroup Inc
Edward WhiteH.C. Wainwright & Co.